Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations.
about
Chronic myeloid leukemia: reminiscences and dreamsManagement of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors TreatmentThe achievement of a 3-month complete cytogenetic response to second-generation tyrosine kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure.The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryPatients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Evolution of therapies for chronic myelogenous leukemia.Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Is there a role for allogeneic transplantation in chronic myeloid leukemia?Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management.An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm.Allogeneic transplantation for CML in the TKI era: striking the right balance.Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase.Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up.Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.
P2860
Q26748769-AC906F36-C12A-4F14-AA31-1B7C7754AFE1Q26766299-0A1A66BA-1031-4758-B374-6405AB2D9FC3Q34163101-86FE5E44-DE79-4923-AFEB-CFAA824060C5Q35634865-413E03E6-3B00-4370-92AA-0EDD46CBF1C6Q35731623-03DFC6BB-CC4D-437E-A84F-1EB486B653D3Q35953410-19C3B24E-72E4-457A-9187-7F4BEF195129Q37026032-0CD3C1AD-D43B-47B7-9CD5-61C5B9C5C58CQ37966915-FCB592A8-B5F8-47A7-9315-9D1179B841A2Q38139571-0BB5E049-2A42-46E2-8533-40F3FD2CAE1CQ38151057-A41D6E46-4F5E-434D-9A7B-31FD073C014EQ38161964-166DB97A-5DC2-4E7C-A4E4-910DCD50B70FQ38204330-ECC6839D-EEE6-4DDF-BC21-A68656BAFBECQ38236642-D398A679-86A1-444C-AE59-1B019D2D361FQ38478174-5291CD64-2093-44B5-9FE2-EA12E0ACAEE4Q38634736-9DA94EE2-506A-4478-9F1B-E7A862AF2D20Q38757051-CD35B788-51E1-4CDA-B236-F14688039D9CQ39202778-BFD8BDE7-2D35-4325-801D-0368924851B1Q39381251-7268A75C-5EC0-440D-9875-EE93E489FC61Q40957470-E0FBD617-7CDC-41E5-BB73-52471469387BQ54340634-1134E77A-6F39-4E9C-975C-0C05EB9F0DF2Q55022248-30644175-603F-43F7-AFFC-A4C9BD1B8427
P2860
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@ast
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@en
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@nl
type
label
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@ast
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@en
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@nl
prefLabel
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@ast
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@en
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@nl
P2093
P2860
P50
P1433
P1476
Results of allogeneic hematopo ...... -ABL1 kinase domain mutations.
@en
P2093
Fabio P S Santos
Gabriela Rondon
Marcos de Lima
Partow Kebriaei
Richard Champlin
Roy B Jones
Uday Popat
P2860
P304
P356
10.1182/BLOOD-2010-08-302679
P407
P577
2010-12-14T00:00:00Z